Not applicableStudy completedNCT06055660What this trial is testingMoesin Expression in Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sohag University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)Study completedNCT00331409What this trial is testingEverolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer OHSU Knight Cancer Institute 23
Large-scale testing (Phase 3)Looking for participantsNCT04510597What this trial is testingComparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 SWOG Cancer Research Network 364
Very early researchNot Yet RecruitingNCT07671417What this trial is testingImaging Study in Metastatic Clear Cell RCC.Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma RayzeBio, Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT01198158What this trial is testingEverolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line TherapyWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 77
Testing effectiveness (Phase 2)Study completedNCT03428217What this trial is testingCANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma Calithera Biosciences, Inc 444
Early research (Phase 1)Active Not RecruitingNCT07000149What this trial is testingInvestigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCCWho this might be right forAdvanced Clear Cell Renal Cell Carcinoma AstraZeneca 9
Testing effectiveness (Phase 2)Study completedNCT00588913What this trial is testingAdoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesWho this might be right forKidney CancerMetastatic Cancer Tokyo Women's Medical University 20
Not applicableStudy completedNCT04415697What this trial is testingIdentification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal CarcinomasWho this might be right forKidney CancerBiomarkersGene Expression Barretos Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01108445What this trial is testingPhase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-clear Cell Renal Cell Carcinoma Duke University 131
Early research (Phase 1)Active Not RecruitingNCT05544929What this trial is testingSafety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersWho this might be right forCarcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more Novartis Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT00455975What this trial is testingHigh-dose Bevacizumab in Advanced Renal Carcinoma PatientsWho this might be right forRenal CancerKidney Cancer SCRI Development Innovations, LLC 119
Testing effectiveness (Phase 2)Study completedNCT00523159What this trial is testingIMA901 in Advanced Renal Cell Carcinoma Patients With Measurable DiseaseWho this might be right forRenal Cell Carcinoma Immatics Biotechnologies GmbH 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04393350What this trial is testingPerioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell CarcinomaWho this might be right forKidney CancerStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8 Emory University 18
Testing effectiveness (Phase 2)Looking for participantsNCT07123090What this trial is testingSasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more Stephanie Berg 25
Early research (Phase 1)Active Not RecruitingNCT03354390What this trial is testingHERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forKidney Cancer National Heart, Lung, and Blood Institute (NHLBI) 17
Testing effectiveness (Phase 2)Ended earlyNCT00126659What this trial is testingSorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831891What this trial is testingFruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forNon-clear Cell Renal Cell Carcinoma RenJi Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00278174What this trial is testingInterferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerWho this might be right forKidney Cancer Case Comprehensive Cancer Center 7